-
Anguille S, Lion E, Van den Bergh J, Van Acker HH, Willemen Y, Smits EL, Van Tendeloo VF, Berneman ZN, 2013: Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy[J]. Hum Vaccin Immunother, 9, 1956-1961. doi: 10.4161/hv.25373
-
Banchereau J, Steinman RM, 1998: Dendritic cells and the control of immunity[J]. Nature, 392, 245-252. doi: 10.1038/32588
-
Brilot F, Strowig T, Munz C, 2008: NK cells interactions with dendritic cells shape innate and adaptive immunity[J]. Front Biosci, 13, 6443-6454.
-
Chen J, Li ZY, Huang SY, Petersen E, Song HQ, Zhou DH, Zhu XQ, 2014: Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice[J]. BMC Infect Dis, 14, 487-. doi: 10.1186/1471-2334-14-487
-
Conzelmann KK, Cox JH, Schneider LG, Thiel HJ, 1990: Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19[J]. Virology, 175, 485-499. doi: 10.1016/0042-6822(90)90433-R
-
Crotty S, 2011: Follicular helper CD4 T cells (TFH)[J]. Annu Rev Immunol, 29, 621-663. doi: 10.1146/annurev-immunol-031210-101400
-
Crotty S, 2014: T follicular helper cell differentiation, function, and roles in disease[J]. Immunity, 41, 529-542. doi: 10.1016/j.immuni.2014.10.004
-
Pagliari D, Frosali S, Landolfi R, Cianci R, 2013: The Role of IL-15 in Human Cancer: Friend or Foe?[J]. Int Trends Immun, 1, 35-42.
-
Eickhoff CS, Vasconcelos JR, Sullivan NL, Blazevic A, Bruna-Romero O, Rodrigues MM, Hoft DF, 2011: Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi[J]. PLoS Negl Trop Dis, 5, e983-. doi: 10.1371/journal.pntd.0000983
-
Fawaz LM, Sharif-Askari E, Menezes J, 1999: Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study[J]. J Immunol, 163, 4473-4480.
-
Fooks AR, Banyard AC, Horton DL, Johnson N, McElhinney LM, Jackson AC, 2014: Current status of rabies and prospects for elimination[J]. Lancet, 384, 1389-1399. doi: 10.1016/S0140-6736(13)62707-5
-
Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, Barrat J, Blanton JD, Briggs DJ, Cleaveland S, 2015: Estimating the global burden of endemic canine rabies[J]. PLoS Negl Trop Dis, 9, e0003709-. doi: 10.1371/journal.pntd.0003709
-
Hargreaves DC, Hyman PL, Lu TT, Ngo VN, Bidgol A, Suzuki G, Zou YR, Littman DR, Cyster JG, 2001: A coordinated change in chemokine responsiveness guides plasma cell movements[J]. J Exp Med, 194, 45-56. doi: 10.1084/jem.194.1.45
-
Hiroi T, Yanagita M, Ohta N, Sakaue G, Kiyono H, 2000: IL-15 and IL-15 Receptor Selectively Regulate Differentiation of Common Mucosal Immune System-Independent B-1 Cells for IgA Responses[J]. The Journal of Immunology, 165, 4329-4337. doi: 10.4049/jimmunol.165.8.4329
-
Hu R, Tang Q, Tang J, Fooks AR, 2009: Rabies in China: an update[J]. Vector Borne Zoonotic Dis, 9, 1-12. doi: 10.1089/vbz.2008.0046
-
Kacani L, Sprinzl GM, Erdei A, Dierich MP, 1999: Interleukin-15 enhances HIV-1-driven polyclonal B-cell response in vitro[J]. Exp Clin Immunogenet, 16, 162-172. doi: 10.1159/000019108
-
Kutzler MA, Robinson TM, Chattergoon MA, Choo DK, Choo AY, Choe PY, Ramanathan MP, Parkinson R, Kudchodkar S, Tamura Y, 2005: Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help[J]. J Immunol, 175, 112-123. doi: 10.4049/jimmunol.175.1.112
-
Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A, 2002: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL[J]. Nature Immunology, 3, 822-829. doi: 10.1038/ni829
-
Manz RA, Hauser AE, Hiepe F, Radbruch A, 2005: Maintenance of serum antibody levels[J]. Annu Rev Immunol, 23, 367-386. doi: 10.1146/annurev.immunol.23.021704.115723
-
Mattei F, Schiavoni G, Belardelli F, Tough DF, 2001: IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation[J]. The Journal of Immunology, 167, 1179-1187. doi: 10.4049/jimmunol.167.3.1179
-
Okada T, Miller MJ, Parker I, Krummel MF, Neighbors M, Hartley SB, O’Garra A, Cahalan MD, Cyster JG, 2005: Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells[J]. PLoS Biol, 3, e150-. doi: 10.1371/journal.pbio.0030150
-
Patidar M, Yadav N, Dalai SK, 2016: Interleukin 15: A key cytokine for immunotherapy[J]. Cytokine Growth Factor Rev, 31, 49-59. doi: 10.1016/j.cytogfr.2016.06.001
-
Perera PY, Lichy JH, Waldmann TA, Perera LP, 2012: The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use[J]. Microbes Infect, 14, 247-261. doi: 10.1016/j.micinf.2011.10.006
-
Rasalingam P, Rossiter JP, Mebatsion T, Jackson AC, 2005: Comparative pathogenesis of the SAD-L16 strain of rabies virus and a mutant modifying the dynein light chain binding site of the rabies virus phosphoprotein in young mice[J]. Virus Res, 111, 55-60. doi: 10.1016/j.virusres.2005.03.010
-
Sage PT, Sharpe AH, 2016: T follicular regulatory cells[J]. Immunol Rev, 271, 246-259. doi: 10.1111/imr.12411
-
Saikh KU, Khan AS, Kissner T, Ulrich RG, 2001: IL-15-induced conversion of monocytes to mature dendritic cells[J]. Clin Exp Immunol, 126, 447-455. doi: 10.1046/j.1365-2249.2001.01672.x
-
Saikh KU, Kissner TL, Nystrom S, Ruthel G, Ulrich RG, 2008: Interleukin-15 increases vaccine efficacy through a mechanism linked to dendritic cell maturation and enhanced antibody titers[J]. Clin Vaccine Immunol, 15, 131-137. doi: 10.1128/CVI.00320-07
-
Shapiro-Shelef M, Calame K, 2005: Regulation of plasma-cell development[J]. Nat Rev Immunol, 5, 230-242. doi: 10.1038/nri1572
-
Slifka MK, Antia R, Whitmire JK, Ahmed R, 1998: Humoral immunity due to long-lived plasma cells[J]. Immunity, 8, 363-372. doi: 10.1016/S1074-7613(00)80541-5
-
Tan J, Wang R, Ji S, Nanjing Agricultural University research group of The Challenge Cup Rabies Research G, Su S, Zhou J, 2017: One Health strategies for rabies control in rural areas of China[J]. Lancet Infect Dis, 17, 365-367. doi: 10.1016/S1473-3099(17)30116-0
-
Tokoyoda K, Hauser AE, Nakayama T, Radbruch A, 2010: Organization of immunological memory by bone marrow stroma[J]. Nat Rev Immunol, 10, 193-200. doi: 10.1038/nri2727
-
Tosic V, Thomas DL, Kranz DM, Liu J, McFadden G, Shisler JL, MacNeill AL, Roy EJ, 2014: Myxoma virus expressing a fusion protein of interleukin-15 (IL15) and IL15 receptor alpha has enhanced antitumor activity[J]. PLoS One, 9, e109801-. doi: 10.1371/journal.pone.0109801
-
Ueno H, Banchereau J, Vinuesa CG, 2015: Pathophysiology of T follicular helper cells in humans and mice[J]. Nat Immunol, 16, 142-152. doi: 10.1038/ni.3054
-
Waldmann TA, Tagaya Y, 1999: The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens[J]. Annu Rev Immunol, 17, 19-49. doi: 10.1146/annurev.immunol.17.1.19
-
Wang Z, Li M, Zhou M, Zhang Y, Yang J, Cao Y, Wang K, Cui M, Chen H, Fu ZF, Zhao L. 2017. A Novel Rabies Vaccine Expressing CXCL13 Enhances Humoral Immunity by Recruiting both T Follicular Helper and Germinal Center B Cells. J Virol, 91. doi: 10.1128/JVI.01956-16
-
Wen Y, Wang H, Wu H, Yang F, Tripp RA, Hogan RJ, Fu ZF, 2011: Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination[J]. J Virol, 85, 1634-1644. doi: 10.1128/JVI.01552-10
-
Zhang Y, Zhou M, Wang Z, Yang J, Li M, Wang K, Cui M, Chen H, Fu ZF, Zhao L, 2016b: Recombinant rabies virus expressing IL-21 enhances immunogenicity through activation of T follicular helper cells and germinal centre B cells[J]. J Gen Virol, 97, 3154-3160. doi: 10.1099/jgv.0.000646
-
Zhao L, Toriumi H, Wang H, Kuang Y, Guo X, Morimoto K, Fu ZF, 2010: Expression of MIP-1alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells[J]. J Virol, 84, 9642-9648. doi: 10.1128/JVI.00326-10
-
Zhou M, Wang L, Zhou S, Wang Z, Ruan J, Tang L, Jia Z, Cui M, Zhao L, Fu ZF, 2015: Recombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs[J]. Oncotarget, 6, 38504-38516. doi: 10.18632/oncotarget.v6i36
-
Zhou M, Zhang G, Ren G, Gnanadurai CW, Li Z, Chai Q, Yang Y, Leyson CM, Wu W, Cui M, Fu ZF, 2013: Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations[J]. PLoS One, 8, e63384-. doi: 10.1371/journal.pone.0063384
-
Zhu S, Guo C, 2016: Rabies Control and Treatment: From Prophylaxis to Strategies with Curative Potential[J]. Viruses, 8, pii: E279-. doi: 10.3390/v8110279